adamantane has been researched along with meglumine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birkemo, LS; Croom, DK; Dezube, M; Dougherty, RW; Ervin, GN; Grizzle, MK; James, MK; Johnson, MF; Mosher, JT; Sugg, EE | 1 |
| Fournie-Zaluski, MC; Maldonado, R; Roques, BP; Valverde, O | 1 |
| Dockray, GJ; Forster, E; Garcia, L; Hill, D; Horwell, DC; Hughes, J; Pritchard, MC; Toescu, E; Woodruff, G | 1 |
| Hinton, JP; Trivedi, BK | 1 |
| Bakris, GL; Flynn, C | 1 |
2 review(s) available for adamantane and meglumine
| Article | Year |
|---|---|
CI-1015. An orally active CCK-B receptor antagonist with an improved pharmacokinetic profile.
Topics: Adamantane; Administration, Oral; Animals; Brain; Humans; Indoles; Meglumine; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Structure-Activity Relationship; Tryptophan | 1998 |
Noninsulin glucose-lowering agents for the treatment of patients on dialysis.
Topics: Adamantane; Biguanides; Diabetic Nephropathies; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Disease Progression; Glucagon-Like Peptides; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Linagliptin; Meglumine; Metformin; Nitriles; Piperidines; Purines; Pyrazines; Pyrrolidines; Quinazolines; Renal Dialysis; Renal Insufficiency, Chronic; Sitagliptin Phosphate; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Triazoles; Uracil; Vildagliptin | 2013 |
3 other study(ies) available for adamantane and meglumine
| Article | Year |
|---|---|
Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligands.
Topics: Adamantane; Amino Acid Sequence; Animals; Appetite Depressants; CHO Cells; Cricetinae; Humans; Indoles; Ligands; Magnetic Resonance Spectroscopy; Male; Meglumine; Molecular Sequence Data; Peptoids; Rats; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Spectrometry, Mass, Fast Atom Bombardment; Tetragastrin; Tryptophan | 1995 |
Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
Topics: Adamantane; Analgesics; Animals; Benzodiazepinones; Dipeptides; Disulfides; Drug Synergism; Enkephalins; Indoles; Male; Meglumine; Nociceptors; Pain Measurement; Phenylalanine; Phenylurea Compounds; Prodrugs; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Regression Analysis; Tail | 1994 |
Characterization of novel peptoid agonists for the CCK-A receptor.
Topics: Adamantane; Amylases; Animals; Calcium; Dose-Response Relationship, Drug; Hormone Antagonists; Indoles; Meglumine; Mice; Pancreas; Peptoids; Phenethylamines; Rats; Receptor, Cholecystokinin A; Receptors, Cholecystokinin | 1996 |